Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Dietary flavonoids have many health-promoting actions, including anticancer activity via proteasome inhibition. Bor-tezomib is a dipeptide boronate proteasome inhibitor that has activity in the treatment of multiple myeloma but is not effective in chronic lymphocytic leukemia (CLL). Although CLL cel...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood
Päätekijät: Liu, Feng-Ting, Agrawal, Samir G., Movasaghi, Zanyar, Wyatt, Peter B., Rehman, Ihtesham U., Gribben, John G., Newland, Adrian C., Jia, Li
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2008
Aiheet:
Neoplasia
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292595/
https://ncbi.nlm.nih.gov/pubmed/18633129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-04-150227
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia